UB SWIFT

Eliminate lengthy, costly licensing negotiations

The University at Buffalo values the mutual benefits of academic-industry collaborations and understands that efficient transactions and financial certainty are important to business. The SWIFT approach empowers both entities to set research and licensing terms at the project planning stage, reducing transaction time and eliminating lengthy, costly negotiations from the partnering process. 

Royalty-free stock photo ID: 1828969643 Smiling young Asian businesswoman going over paperwork with a male colleague during a meeting around a boardroom table.

Efficient transactions and financial certainty are important

UB SWIFT PREFERRED LICENSE TERMS

The university offers UB SWIFT terms as a beneficial alternative to the standard option [terms in industry sponsored research agreements] (see comparison chart).

  • Company locks in preferred exclusive license terms for all intellectual property resulting from the project.
  • Expedited transaction time through use of the standard SWIFT agreement.
  • Company part of SWIFT decision: the company, UB and the principal investigator will decide jointly if the project is suitable for UB SWIFT.
  • Exception requests will be considered for university-owned, background intellectual property not included in the exclusive license terms.
  • **UB offers a special version of UB SWIFT preferred exclusive license terms for UB CAT life sciences company projects.
Terms UB SWIFT UB Standard Option
Preferred Terms Fee 10% of the contract budget or $15,000, whichever is greater n/a
Royalty Rate

1% after exceeding $50 million in cumulative net sales if market entry requires human trials and regulatory approval; or

1% after exceeding $20 million in cumulative net sales for all other technology

Negotiated
License issue fee None Negotiated
Minimum Annual Royalties None Negotiated
Due Diligence Milestones None (unless the project includes federal funding) Negotiated
Sublicensing Granted Negotiated
Patent Prosecution Management Company Manages Negotiated

UB SWIFT terms support life sciences R&D projects

UB offers a special version of UB SWIFT preferred exclusive license terms for UB CAT company projects (see comparison):

  • UB CAT projects may have the SWIFT upfront preferred terms fee waived ($0). Explore the UB CAT program to learn more.
  • The cumulative nets sales amount before royalty payments are reduced by 20%, but all other SWIFT benefits remain.
  • SWIFT terms are subject to PI approval.
Terms UB SWIFT FOR UB CAT UB Standard Option
Preferred Terms Fee $0. The Preferred Terms Fee is waived for UB CAT funded projects.
n/a
Royalty Rate

1% after exceeding $40M in cumulative net sales if market entry requires human trials and regulatory approval;

or

1% after exceeding $16M in cumulative net sales for all other technology

Negotiated
License issue fee None Negotiated
Minimum Annual Royalties None Negotiated
Due Diligence Milestones None (unless the project includes federal funding) Negotiated
Sublicensing Granted Negotiated
Patent Prosecution Management Company Manages Negotiated